Helping to gain access to Cystic Fibrosis medicines for all.
We are working with generic manufacturers to supply modulator medicines for people with CF.
@VertexPharma is patent holder w/unilateral power to set price & distribution of #kaftrio w/cash $6.6B CF Revenues 2015–20 $18.5B, projected to 2021 $31.5B w/CF R&D since 2008 at $12.5B. Former CEO, now Executive Chairman J.Leiden paid $166.3mn since 2011 #StandUp4HumanRights
#trikafta#kaftrio is $311,000 p.a. 4 life in #usa. ICER: ‘a remarkable advance for the majority of people living with CF. Unfortunately (@VertexPharma)..leveraged its monopoly to set a price-costing many millions of dollars over the lifetime of an average patient’ @drtlaleng
Compassion can't come w/ strings attached nor be a sales tool. The fact is 000's are dying w/ #cysticfibrosis illness in absence of your compassion Dr Kewalramani. Global fund 4 those w/immediately life-threatening CF is needed now @UNHumanRights@drtlaleng#StandUp4HumanRights
Registry is gr8 news but what MUST come too is treatments like #kaftrio#orkambi#kalydeco from @VertexPharma to #cysticfibrosis lives once diagnosed. Same in #india#brazil ++ Ethnic blindside & pure greed from Dr Kewalramani's strategy sees those regions as not 'profitable'
Please read @drtlaleng “previous misconception held by many that (CF) did not occur in indigenous Africans is simply not true. It is very likely that most children born with the disease in Africa are dying very young, undiagnosed or misdiagnosed.”#StandUp4HumanRights#HumanRights
“I know there is someone out there somewhere who can help me and I’m hoping that someone is you. You truly have the power here to save my life” (Dr Kewalramani) Juliet never saw a response. She died waiting, in June. RIP @VertexPharma@drtlaleng#StandUp4HumanRights#HumanRights